Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT07646652
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Lewy Body Disease

Eligibility Criteria

Sex
ALL
Age
40 Years - 85 Years
Healthy Volunteers
Accepted

Interventions

  • LBD Biomarker Education and Disclosure — OTHER
    In-depth interviews as well as questionnaires will be conducted with individuals who have preclinical (early stage) or symptomatic LBD.

Study Details

The goal of the study is to assess if learning one's Lewy Body Dementia (LBD) biomarker test result impacts longitudinal psychosocial and behavioral responses and to identify factors that moderate and mediate these outcomes.

Key Dates

Start date
Nov 30, 2026
Status verified
Jun 2026
Primary completion
Nov 30, 2030
Completion
Nov 30, 2030

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Symptomatic Lewy body disease (LBD)
    Participants undergo testing for alpha-synuclein, participate in a disclosure visit for their alpha-synuclein status, and fill out questionnaires before and after disclosure to assess their reaction to this information.
  • Arm: Asymptomatic (participants without symptoms of LBD or MSA)
    Participants underwent testing for alpha-synuclein. They will participate in a disclosure visit for their alpha-synuclein status and fill out questionnaires before and after disclosure to assess their reaction to this information.

Primary Outcome Measure

Change in distress scale score as measured by the Impact of Event Scale-Revised [ Time Frame: Baseline, Day 14, Day 30, Day 182 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Hannah Lawrence
[email protected]

Find similar trials in Stanford, CA

By research site
Stanford University· Stanford, CA

Related Studies